
We're doomed we're saved #2
09/01/22 • 34 min
GERMAN EPISODE Antibiotika wurden einst als Heilbringer der Menschheit gefeiert und haben dazu beigetragen die durchschnittliche Lebenserwartung stark zu erhöhen. Doch schon in den frühen Tagen warnte der Finder des Penicillins, Sir Alexander Fleming, vor dem unbedachten und verschwenderischen Umgang mit diesen Wundermedikamenten. In dieser Folge beleuchten Andreas Horchler und Louise von Stechow die weltweite Gesundheitskrise, die von antibiotikaresistenten Bakterien hervorgerufen wird und besprechen ihre Ursachen und potentielle Gegenmaßnahmen.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: CDC via Unsplash
References
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/ (antibiotic resistance overview)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354621/ (antibiotic resistance overview, altered life expectancy)
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext (antibiotic resistance overview, Lancet study)
- https://www.bbc.com/news/health-60058120 (antibiotic resistance overview, Lancet study overview)
- https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality (COVID death statistics WHO)
- https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html (C diff)
- https://www.cell.com/trends/genetics/fulltext/S0168-9525(20)30206-7 (Horizontal gene transfer)
- https://wellcome.org/news/why-is-it-so-hard-develop-new-antibiotics (the difficulties in developing novel antibiotics
- https://www.nature.com/articles/d41586-020-02884-3 (Nature, why big pharma abandoned antibiotics)
- https://www.nature.com/articles/d41586-018-02475-3 (Nature - 4 stories of antibiotic breakthroughs)
- https://www.umu.se/en/news/-new-group-of-antibacterial-molecules-identified_11112855/ (new antibiotics, Karolinska and Uni Bonn)
- https://pubmed.ncbi.nlm.nih.gov/26089440/#:~:text=Teixobactin%20is%20a%20recently%20described,(provisionally%20named%20Eleftheria%20terrae). (new antibiotics, Teixobactin)
- https://www.nature.com/articles/s41586-021-03899-0 (new antibiotics, rational design)
- https://news.mit.edu/2020/artificial-intelligence-identifies-new-antibiotic-0220#:~:text=Using%20a%20machine%2Dlearning%20algorithm,resistant%20to%20all%20known%20antibiotics. (new antibiotics, MIT AI)
GERMAN EPISODE Antibiotika wurden einst als Heilbringer der Menschheit gefeiert und haben dazu beigetragen die durchschnittliche Lebenserwartung stark zu erhöhen. Doch schon in den frühen Tagen warnte der Finder des Penicillins, Sir Alexander Fleming, vor dem unbedachten und verschwenderischen Umgang mit diesen Wundermedikamenten. In dieser Folge beleuchten Andreas Horchler und Louise von Stechow die weltweite Gesundheitskrise, die von antibiotikaresistenten Bakterien hervorgerufen wird und besprechen ihre Ursachen und potentielle Gegenmaßnahmen.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: CDC via Unsplash
References
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/ (antibiotic resistance overview)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354621/ (antibiotic resistance overview, altered life expectancy)
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext (antibiotic resistance overview, Lancet study)
- https://www.bbc.com/news/health-60058120 (antibiotic resistance overview, Lancet study overview)
- https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality (COVID death statistics WHO)
- https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html (C diff)
- https://www.cell.com/trends/genetics/fulltext/S0168-9525(20)30206-7 (Horizontal gene transfer)
- https://wellcome.org/news/why-is-it-so-hard-develop-new-antibiotics (the difficulties in developing novel antibiotics
- https://www.nature.com/articles/d41586-020-02884-3 (Nature, why big pharma abandoned antibiotics)
- https://www.nature.com/articles/d41586-018-02475-3 (Nature - 4 stories of antibiotic breakthroughs)
- https://www.umu.se/en/news/-new-group-of-antibacterial-molecules-identified_11112855/ (new antibiotics, Karolinska and Uni Bonn)
- https://pubmed.ncbi.nlm.nih.gov/26089440/#:~:text=Teixobactin%20is%20a%20recently%20described,(provisionally%20named%20Eleftheria%20terrae). (new antibiotics, Teixobactin)
- https://www.nature.com/articles/s41586-021-03899-0 (new antibiotics, rational design)
- https://news.mit.edu/2020/artificial-intelligence-identifies-new-antibiotic-0220#:~:text=Using%20a%20machine%2Dlearning%20algorithm,resistant%20to%20all%20known%20antibiotics. (new antibiotics, MIT AI)
Previous Episode

We're doomed we're saved #1
Die Biorevolution - Risiken und Versprechen
GERMAN EPISODE Die Biorevolution bringt viele neue Technologien, mit großen Versprechungen, aber auch unkalkulierbaren Risiken. In dieser Folge geben Andreas Horchler und Louise von Stechow einen Überblick über die Technologien der Biorevolution und sprechen über die Möglichkeit den Menschen selbst, seine Gene und sein Gehirn zu revolutionieren und über die Unmöglichkeit biologische Agenzien zu kontrollieren, die sich nicht um menschengemachte Regeln, Grenzen und ethische Bedenken kümmern. Erscheint montatlich am 1.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: Isis França via Unsplash
References https://www.mckinsey.com/business-functions/mckinsey-digital/our-insights/how-the-bio-revolution-could-transform-the-competitive-landscape https://peh-med.biomedcentral.com/articles/10.1186/s13010-020-00089-0 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193163/ https://theconversation.com/science-fiction-explores-the-interconnectedness-revealed-by-the-coronavirus-pandemic-139021 https://lab.cccb.org/en/terraforming-the-earth-redesigning-the-world/ https://www.nature.com/articles/429591b
Next Episode

We're doomed we're saved #3
Editiertes Erbgut - Reparaturen und Upgrades
GERMAN EPISODE Gentherapien und Geneditierungsverfahren versprechen die Heilung von Krankheiten von Hämophilie bis Krebs. Sie erlauben aber auch genetische Upgrades – die uns schneller, schlauer und schöner machen könnten. In dieser Folge unterhalten sich Andreas Horchler und Louise von Stechow über die Möglichkeiten die Gentherapien und die neuentdeckte Technologie CRISPR-Cas bieten, welche klinischen Erfolge erzielt wurden und welche ethischen Konsequenzen diese Methoden mit sich bringen.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: Alain Pham Via Unsplash
References • https://www.mckinsey.com/industries/life-sciences/our-insights/the-bio-revolution-innovations-transforming-economies-societies-and-our-lives • https://www.mckinsey.com/industries/life-sciences/our-insights/gene-therapy-coming-of-age-opportunities-and-challenges-to-getting-ahead • https://endpts.com/vertex-looking-to-right-their-rd-ship-flashes-data-suggesting-their-sickle-cell-crispr-therapy-is-working/
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-biorevolution-podcast-360954/were-doomed-were-saved-2-51934879"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to we're doomed we're saved #2 on goodpods" style="width: 225px" /> </a>
Copy